Developing Medical Innovation

We develop new technologies from the NHS and beyond to improve patient care

Realising Potential

Medovate is a dynamic medical device company dedicated to the development and commercialisation of innovative medical technologies created within the NHS.

Medovate provides technical, management and financial support to develop medical devices through clinical trials, regulatory approval and market launch, in order to improve patient safety and healthcare delivery.

Our current pipeline of novel medical technologies is focussed on anaesthesia, airway, critical care and surgery.

** COVID-19 pandemic: Medovate remains fully operational during this time. Team members are fully able to work from home and can be contacted via phone and e-mail. Please see post in 'News' for full details.**

Read More

Latest News

Keep up to date with Medovate News & Events


Medovate partners with NYSORA for launch of innovative regional anesthesia solution SAFIRA™ across the United States

2nd June, 2020

Medovate has announced that they will be partnering with the New York School of Regional Anesthesia (NYSORA) to support the launch of SAFIRA™, their innovation for regional anesthesia in the United States.


Medovate developing new PPE face mask to help front line clinicians with coronavirus

30th April, 2020

Medovate is developing an innovative face mask incorporating a specialised filter which has been proven to be an effective barrier against viruses.


Medovate secures exclusive partnerships with USA distributors to launch regional anaesthesia innovation SAFIRA

14th April, 2020

Medovate has concluded agreements with three USA-based companies to act as the exclusive distributors for its innovative medical technology for regional anaesthesia, SAFIRA (Safer Injection for Regional Anaesthesia) across the United States of America.